DrugPatentWatch Database Preview
GARDASIL Drug Profile
Summary for Tradename: GARDASIL
| Patents: | 5 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for GARDASIL |
Recent Clinical Trials for GARDASIL
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Merck Sharp & Dohme Corp. | Phase 3 |
| Alessandro Ghelardi | Phase 3 |
| University Health Network, Toronto | Phase 1 |
Patent Text Search: US Patents for GARDASIL
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | GARDASIL | human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | INJECTION, SUSPENSION | 125126 | 001 | 2006-06-08 | Start Trial | Chevron Phillips Chemical Company LP (The Woodlands, TX) | 2031-06-06 | search | ||
| Merck Sharp & Dohme Corp. | GARDASIL | human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | INJECTION, SUSPENSION | 125126 | 001 | 2006-06-08 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | search | ||
| Merck Sharp & Dohme Corp. | GARDASIL | human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | INJECTION, SUSPENSION | 125126 | 001 | 2006-06-08 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | search | ||
| Merck Sharp & Dohme Corp. | GARDASIL | human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | INJECTION, SUSPENSION | 125126 | 001 | 2006-06-08 | Start Trial | ALDERBIO HOLDINGS LLC (Las Vegas, NV) | 2028-11-25 | search | ||
| Merck Sharp & Dohme Corp. | GARDASIL | human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | INJECTION, SUSPENSION | 125126 | 001 | 2006-06-08 | Start Trial | Progenra, Inc. (Malvern, PA) The Children\'s Hospital of Philadelphia (Philadelphia, PA) | 2035-07-31 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for GARDASIL
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2015164951 | Start Trial |
| South Korea | 20110091780 | Start Trial |
| European Patent Office | 2367570 | Start Trial |
| New Zealand | 601583 | Start Trial |
| Mexico | 2008014692 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
